Going There with Dr. Mike Until the Ribbon Breaks on the Relationship Between Anxiety and Alcoholism
For the final episode Going There with Dr. Mike Season 5, Until the Ribbon Breaks’ Pete Lawrie-Winfield joins to talk about the link between anxiety and the devastating cycle of addiction. Listen to the important conversation now.
The songwriter and musician discusses the temptation of soothing feelings of anxiety with alcohol or other substances, as well as the ultimate pit of addiction that occurs as a result for many. Lawrie-Winfield explores examples from his own mental health journey and showcases how such instances have changed both him as a person and his work as an artist.
Listen to Until The Ribbon Breaks chat about all of this and more in the new episode of Going There with Dr. Mike. You can also, check out UTRB’s music, tour info and merch at untiltheribbonbreaks.com.
Until The Ribbon Breaks new album VISITOR is out now! Check it out here. You can also check the music video for "HUMAN" here as well as a special live version here.
He also JUST released this beautiful live video for "HUMAN" here: https://youtu.be/KuDL6UEzeWo?si=aXEPY2Av_F0H-NfO
Then make sure to like, review, and subscribe to the show, presented by the Consequence Podcast Network and Sound Mind Live, wherever you get your podcasts.
Season 5 of Going There with Dr. Mike is brought to you by Johnson & Johnson who believes that health is everything. Their strength in healthcare innovation empowers them to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through their expertise in Innovative Medicine and MedTech, they are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at www.jnj.com @JanssenUS and @JNJInnovMed on Twitter.
This season is also brought to you by AbbVie, who is driving the pursuit of better mental health. Over the last 30 years, AbbVie’s scientists and clinicians have worked to tackle the complexity of mental illness and today offer a portfolio of medicines and a pipeline of innovation that spans depression, anxiety, bipolar 1 disorder, and schizophrenia. To learn more about AbbVie’s work to support individuals throughout their mental health journey, please visit www.AbbVie.com or follow at AbbVie on Twitter, Facebook, Instagram, YouTube, and LinkedIn.
This episode is also brought to you by Alkermes. Alkermes is a global biopharmaceutical company developing innovative medicines in the field of neuroscience with products that treat alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder. To learn more, please visit Alkermes' website at www dot AL-ker-mees dot com or follow at Alkermes on Twitter and LinkedIn.